🇺🇸 FDA
Pipeline program

Bumetanide

CURE 07120492

Phase 1 small_molecule completed

Quick answer

Bumetanide for Seizures is a Phase 1 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
CATALYST PHARMACEUTICALS, INC.
Indication
Seizures
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials